Pyroptosis of Macrophages Induced by Clostridium perfringens Beta-1 Toxin

Siyu Zhang1, Lingling Ma1, Fuyang Song1

  • 1Key Laboratory of Ministry of Education for Conservation and Utilization of Special Biological Resources in the Western China, College of Life Science, Ningxia University, Yinchuan 750021, China.

Toxins
|June 27, 2023
PubMed

Insights

Clostridium perfringens beta-1 toxin (CPB1) triggers pyroptosis, a programmed cell death, in macrophages and endothelial cells. This inflammatory response involves the NLRP3 inflammasome and Caspase-1, offering potential therapeutic targets for C. perfringens infections.

Area of Science:

  • Microbiology
  • Immunology
  • Cell Biology

Background:

  • Clostridium perfringens beta-1 toxin (CPB1) is a key virulence factor in necrotizing enteritis and enterotoxemia.
  • The role of CPB1 in inducing pyroptosis, an inflammatory form of programmed cell death, remained uninvestigated.

Purpose of the Study:

  • To investigate whether CPB1 induces pyroptosis in host cells.
  • To elucidate the molecular mechanisms underlying CPB1-induced pyroptosis.

Main Methods:

  • Recombinant CPB1 (rCPB1) was expressed and purified.
  • Cytotoxicity was assessed using CCK-8 assays.
  • Pyroptosis was analyzed via quantitative real-time PCR, immunoblotting, ELISA, immunofluorescence, and electron microscopy.
  • Inflammasome activation was studied using the inhibitor MCC950.

Main Results:

  • Purified rCPB1 exhibited moderate cytotoxicity in RAW264.7, NCM460, and HUVEC cells.
  • rCPB1 induced pyroptosis in macrophages (RAW264.7) and HUVEC cells via a Caspase-1-dependent pathway.
  • rCPB1 treatment promoted NLRP3 inflammasome assembly and Caspase-1 activation.
  • Activated Caspase-1 led to Gasdermin D cleavage, pore formation, and release of IL-18 and IL-1β, causing pyroptosis.

Conclusions:

  • CPB1 induces pyroptosis in macrophages and HUVEC cells through the NLRP3 inflammasome and Caspase-1 pathway.
  • NLRP3 inflammasome activation is a critical mechanism in CPB1-mediated cell death.
  • Targeting the NLRP3 inflammasome may represent a novel therapeutic strategy for Clostridium perfringens diseases.